全文获取类型
收费全文 | 6407篇 |
免费 | 624篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 66篇 |
儿科学 | 192篇 |
妇产科学 | 98篇 |
基础医学 | 968篇 |
口腔科学 | 117篇 |
临床医学 | 775篇 |
内科学 | 1303篇 |
皮肤病学 | 79篇 |
神经病学 | 564篇 |
特种医学 | 280篇 |
外国民族医学 | 1篇 |
外科学 | 624篇 |
综合类 | 142篇 |
一般理论 | 2篇 |
预防医学 | 701篇 |
眼科学 | 109篇 |
药学 | 599篇 |
中国医学 | 10篇 |
肿瘤学 | 424篇 |
出版年
2022年 | 45篇 |
2021年 | 88篇 |
2020年 | 66篇 |
2019年 | 79篇 |
2018年 | 88篇 |
2017年 | 96篇 |
2016年 | 97篇 |
2015年 | 124篇 |
2014年 | 154篇 |
2013年 | 237篇 |
2012年 | 324篇 |
2011年 | 349篇 |
2010年 | 187篇 |
2009年 | 183篇 |
2008年 | 341篇 |
2007年 | 304篇 |
2006年 | 333篇 |
2005年 | 290篇 |
2004年 | 283篇 |
2003年 | 240篇 |
2002年 | 203篇 |
2001年 | 208篇 |
2000年 | 215篇 |
1999年 | 183篇 |
1998年 | 80篇 |
1997年 | 70篇 |
1996年 | 68篇 |
1995年 | 77篇 |
1994年 | 58篇 |
1993年 | 61篇 |
1992年 | 127篇 |
1991年 | 143篇 |
1990年 | 117篇 |
1989年 | 134篇 |
1988年 | 106篇 |
1987年 | 126篇 |
1986年 | 114篇 |
1985年 | 131篇 |
1984年 | 90篇 |
1983年 | 57篇 |
1982年 | 47篇 |
1981年 | 52篇 |
1980年 | 37篇 |
1979年 | 66篇 |
1978年 | 46篇 |
1977年 | 41篇 |
1976年 | 42篇 |
1975年 | 59篇 |
1974年 | 42篇 |
1973年 | 45篇 |
排序方式: 共有7054条查询结果,搜索用时 0 毫秒
91.
Upon treatment with N-methyl-N'-nitro-N-nitroso-guanidine (MNNG),human cell strains characterized as either proficient or defectiveboth in repair of alkyla-tion-damaged DNA and in supportingthe growth of MNNG-treated adenovirus (Mer+ and Mer pheno-types(1,2), all underwent a rapid relaxation of nucleokl DNA, asjudged by sedimentation in 1530% neutral sucrose gradients.DNA in the repair-proficient Mer+ strains (normal fibroblastand tumor) was restored to the rapidly-sedimenting (control)form within 24 h after the removal of MNNG. In contrast,nucleoid DNA of the repair-deficient Mer tumor strainsremained slowly-sedimenting even after 48 h of incubation. Thedelayed recovery of Mer nucleoid DNA was specific forMNNG damage, since after u.v. irradiation, to which Mer+ andMer strains are equally resistant (2), all cell linestested underwent DNA relaxation within the first hour afterirradiation (3 J/m2) and regenerated rapidly-sedimenting nucleoidswithin 46 h of repair incubation. 相似文献
92.
O'Sullivan AJ Kennedy MC Casey JH Day RO Corrigan B Wodak AD 《The Medical journal of Australia》2000,173(6):323-327
OBJECTIVE: To document adverse effects of anabolic-androgenic steroid (AAS) use in community-based users attending a medical clinic. DESIGN AND SETTING: Prospective recruitment, questionnaire-based interview, physical examination and investigations, with follow-up, of people who attended, anonymously, an inner-city hospital clinic established specifically to examine AAS use. PARTICIPANTS: 58 men, comprising 27 past AAS users, 14 present users and 17 potential users (who formed the control group). MAIN OUTCOME MEASURE: Clinical adverse effects and abnormal laboratory findings. RESULTS: Cyclical use of oral and intramuscular, human and veterinary AASs were reported. The most commonly reported source of AASs was friends (59%), gymnasiums (25%) and doctors (14%). The most common reported adverse effects were alterations in libido (61%), changes in mood (48%), reduced testis volume (46%) and acne (43%). Although mean systolic and diastolic blood pressure was not significantly different between groups, five present (29%), 10 past (37%) and one potential user (8%) were hypertensive. Gynaecomastia was found in 10 past users (37%; P<0.01 v. potential users), two present users (12%) and no potential users. Mean testis volume was significantly smaller in present users (18 mL; P<0.02) than in the other groups. Twenty past users (83%), eight present users (62%) and five potential users (71%) had abnormal liver function test results (P=0.5). After discussion of test results, only 11 participants (19%) reported they would not use AASs in the future. CONCLUSIONS: Adverse effects were reported by or detected in most of the AAS users who attended the clinic. Despite awareness of adverse consequences, most participants planned future use of AASs. 相似文献
93.
94.
OBJECTIVES: To determine the predictors of bone mass (in lumbar spine and femoral neck) in healthy older men living in the community. DESIGN: Cross-sectional study. Bone mineral density (BMD) was measured and known predictors of bone mass and bone turnover were assessed. SUBJECTS AND SETTING: 113 independent, healthy men (70 years and over), not taking glucocorticoid therapy and without medical conditions known to affect bone mass and bone turnover, were recruited from recreational and sports clubs in southern Sydney in April/May 1997. MAIN OUTCOME MEASURES: BMD (measured by dual-energy x-ray absorptiometry); known predictors of bone mass (height; weight; body mass index; calcium level; serum 25-hydroxyvitamin D and free testosterone levels); and markers of bone turnover (serum bone Gla protein and procollagen-1 concentrations, and urinary deoxypyridinoline excretion rates). RESULTS: The mean age of the men was 76.6 years (range, 70-92 years). Mean (SE) BMD of the lumbar spine was 1.143 (0.019) g/cm2 and that of the femoral neck was 0.897 (0.013) g/cm2. BMD values indicating osteoporosis were found in the lumbar spine in 13 men (11.5%) and in the femoral neck in 35 men (31%). The best predictor of lumbar spine BMD was weight (R = 0.37; P = 0.001), and weight- and age-predicted femoral-neck BMD (R = 0.49; P < 0.001). The study group was analysed in two groups with BMD higher or lower than median bone mass corrected for age. Men with lower femoral-neck BMD for age had significantly lower weight, lower lean mass and higher bone Gla protein concentrations. In addition, men with lower lumbar spine BMD for age also had significantly lower fat mass. CONCLUSIONS: These data indicate that measures of body composition, such as weight and lean mass, are the main predictors of bone mass in healthy, community-dwelling older men. 相似文献
95.
COX-2 inhibitors 总被引:2,自引:0,他引:2
Cyclooxygenase-2 (COX-2) inhibitors constitute a new group of non-steroidal anti-inflammatory drugs (NSAIDs) which, at recommended doses, block prostaglandin production by cyclooxygenase-2, but not by cyclooxygenase-1. Two COX-2 inhibitors are currently available in Australia--celecoxib, which is taken twice daily, and rofecoxib, which is taken once daily. Both drugs act rapidly in providing pain relief and their anti-inflammatory analgesic effect in osteoarthritis and rheumatoid arthritis is equivalent to standard doses of non-selective NSAIDs. Celecoxib and rofecoxib show significantly lower incidences of gastrotoxicity (as measured by endoscopic studies and gastrointestinal ulcers and bleeds) than non-selective NSAIDs. There is Level 2 evidence that COX-2 inhibitors: reduce pain in classic pain models--third-molar extraction, dysmenorrhoea and after orthopaedic surgery; reduce pain and disability in osteoarthritis of the hip and knee; and reduce pain and disability in rheumatoid arthritis. Other adverse effects, such as interference with antihypertensive agents and the potential to produce renal dysfunction in patients with compromised renal function by COX-2 inhibitors, seem similar to those of non-selective NSAIDs. 相似文献
96.
Tolerability of paracetamol. 总被引:2,自引:0,他引:2
The excellent tolerability of therapeutic doses of paracetamol (acetaminophen) is a major factor in the very wide use of the drug. The major problem in the use of paracetamol is its hepatotoxicity after an overdose. Hepatotoxicity has also been reported after therapeutic doses, but critical analysis indicates that most patients with alleged toxicity from therapeutic doses have taken overdoses. Importantly, prospective studies indicate that therapeutic doses of paracetamol are an unlikely cause of hepatotoxicity in patients who ingest moderate to large amounts of alcohol. Controlled clinical trials have found that paracetamol is very well tolerated by the gastrointestinal tract. While variable results have been found in case control studies, most studies have shown no change or a small increase in the relative risk of perforations, ulcer or bleeding in the upper gastrointestinal tract. However, associations between the use of paracetamol and gastrointestinal toxicity, as well as with chronic renal disease and asthma, are very likely to reflect biases in some case control studies. In particular, such biases may be caused by the perceived high tolerability of paracetamol in these diseases. The consequent use of paracetamol in these diseases states then leads to an apparent association between paracetamol and the disease. Despite metabolism of paracetamol to reactive compounds, hypersensitivity reactions are rare, although urticaria occurs in occasional patients. Paracetamol appears to be well tolerated during pregnancy although prospective studies are required. 相似文献
97.
Wendy R Parulekar Andrew G Day Jon A Ottaway Lois E Shepherd Maureen E Trudeau Vivien Bramwell Mark Levine Kathleen I Pritchard 《Journal of clinical oncology》2005,23(25):6002-6008
PURPOSE: To investigate the therapeutic impact of chemotherapy-induced amenorrhea in premenopausal patients with breast cancer. PATIENTS AND METHODS: We conducted a retrospective cohort study of a National Cancer Institute of Canada Clinical Trials Group phase III trial involving premenopausal patients randomized to receive cyclophosphamide, methotrexate, and fluorouracil (CMF), versus intensive cyclophosphamide, epirubicin, and fluorouracil (CEF). The objectives of our study were to describe the incidence of amenorrhea at 6 and 12 months post-random assignment and to determine the association of amenorrhea with relapse-free and overall survival. RESULTS: Data on 442 patients were used in our analyses. Despite the higher cumulative dose of cyclophosphamide in the CMF treatment arm, at 6 months post-random assignment, the rate of amenorrhea was higher in the CEF group (relative risk, 1.2; 95% CI, 1.0 to 1.3), with no difference at 12 months. In the receptor-positive subgroup, 6-month amenorrhea rates were not associated with prognosis. In contrast, amenorrhea at 12 months was significantly associated with relapse-free survival (hazard ratio, 0.51; 95% CI, 0.32 to 0.82; P = .005) and overall survival (hazard ratio, 0.40; 95% CI, 0.22 to 0.72; P = .002). CONCLUSION: Late chemotherapy-induced amenorrhea seems to be associated with improved outcome in patients with premenopausal, receptor-positive breast cancer. 相似文献
98.
Chun‐Liang Tung Da‐Tong Ju Bharath Kumar Velmurugan Bo Ban Tran D. Dung Dennis J.‐Y. Hsieh Vijaya P. Viswanadha Cecilia H. Day Yueh‐Min Lin Chih‐Yang Huang 《Environmental toxicology》2019,34(12):1320-1328
Carthamus tinctorius L. (Compositae) is used in Chinese medicine to treat heart disease and inflammation. In our previous study, we found that C. tinctorius L. inhibited lipopolysaccharides (LPS)‐induced tumor necrosis factor‐alpha (TNF‐α) activation, JNK expression, and apoptosis in H9c2 cardiomyoblast cells. The present study was performed to investigate the protective effect of C. tinctorius extract (CTF) on LPS‐challenged H9c2 myocardioblast cell and to explore the possible underlying mechanism. Cell viability assay showed that LPS treatment decreased the cell viability of H9c2 cell, whereas CTF treatment reversed LPS cytotoxicity in a dose‐dependent manner, especially in the LPS + CTF 25 (μg/mL) group. LPS treatment‐induced apoptosis was determined by transferase‐mediated dUTP nick end labeling assay, and by Western blot. LPS‐induced apoptotic bodies were decreased following CTF treatment. Expression of TNF‐α, FAS‐L, FAS, FADD, caspase‐8, BID, and t‐BID was significantly increased in LPS‐treated H9c2 cells. In contrast, it was significantly suppressed by the administration of CTF extract. In addition, CTF treatment activates antiapoptotic proteins, Bcl‐2 and p‐Bad, and downregulates Bax, cytochrome‐c, caspase‐9, caspase‐3, and apoptosis‐inducing factor expression. Furthermore, CTF exerted cytoprotective effects by activating insulin‐like growth factor‐I (IGF‐I) signaling pathway leading to downregulation of the apoptotic proteins involved in FAS death receptor pathway. In addition, AG1024 and IGF‐I receptor (IGF‐IR) inhibitor and siRNA silencing reverses the effect of CTF implying that CTF functions through the IGF‐IR pathway to inhibit LPS‐induced H9c2 apoptosis. These results suggest that treatment with CTF extract prevented the LPS‐induced apoptotic response through IGF‐I pathway. 相似文献
99.
Skinner J Mee TJ Blackwell RP Maslanyj MP Simpson J Allen SG Day NE Cheng KK Gilman E Williams D Cartwright R Craft A Birch JM Eden OB McKinney PA Deacon J Peto J Beral V Roman E Elwood P Alexander FE Mott M Chilvers CE Muir K Doll R Taylor CM Greaves M Goodhead D Fry FA Adams G Law G;United Kingdom Childhood Cancer Study Investigators 《British journal of cancer》2002,87(11):1257-1266
The United Kingdom Childhood Cancer Study, a population-based case-control study covering the whole of Great Britain, incorporated a pilot study measuring electric fields. Measurements were made in the homes of 473 children who were diagnosed with a malignant neoplasm between 1992 and 1996 and who were aged 0-14 at diagnosis, together with 453 controls matched on age, sex and geographical location. Exposure assessments comprised resultant spot measurements in the child's bedroom and the family living-room. Temporal stability of bedroom fields was investigated through continuous logging of the 48-h vertical component at the child's bedside supported by repeat spot measurements. The principal exposure metric used was the mean of the pillow and bed centre measurements. For the 273 cases and 276 controls with fully validated measures, comparing those with a measured electric field exposure >/=20 V m(-1) to those in a reference category of exposure <10 V m(-1), odds ratios of 1.31 (95% confidence interval 0.68-2.54) for acute lymphoblastic leukaemia, 1.32 (95% confidence interval 0.73-2.39) for total leukaemia, 2.12 (95% confidence interval 0.78-5.78) for central nervous system cancers and 1.26 (95% confidence interval 0.77-2.07) for all malignancies were obtained. When considering the 426 cases and 419 controls with no invalid measures, the corresponding odds ratios were 0.86 (95% confidence interval 0.49-1.51) for acute lymphoblastic leukaemia, 0.93 (95% confidence interval 0.56-1.54) for total leukaemia, 1.43 (95% confidence interval 0.68-3.02) for central nervous system cancers and 0.90 (95% confidence interval 0.59-1.35) for all malignancies. With exposure modelled as a continuous variable, odds ratios for an increase in the principal metric of 10 V m(-1) were close to unity for all disease categories, never differing significantly from one. 相似文献